» Articles » PMID: 34454423

Evaluating the Impact of Covariate Lookback Times on Performance of Patient-level Prediction Models

Overview
Publisher Biomed Central
Date 2021 Aug 29
PMID 34454423
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The goal of our study is to examine the impact of the lookback length when engineering features to use in developing predictive models using observational healthcare data. Using a longer lookback for feature engineering gives more insight about patients but increases the issue of left-censoring.

Methods: We used five US observational databases to develop patient-level prediction models. A target cohort of subjects with hypertensive drug exposures and outcome cohorts of subjects with acute (stroke and gastrointestinal bleeding) and chronic outcomes (diabetes and chronic kidney disease) were developed. Candidate predictors that exist on or prior to the target index date were derived within the following lookback periods: 14, 30, 90, 180, 365, 730, and all days prior to index were evaluated. We predicted the risk of outcomes occurring 1 day until 365 days after index. Ten lasso logistic models for each lookback period were generated to create a distribution of area under the curve (AUC) metrics to evaluate the discriminative performance of the models. Calibration intercept and slope were also calculated. Impact on external validation performance was investigated across five databases.

Results: The maximum differences in AUCs for the models developed using different lookback periods within a database was < 0.04 for diabetes (in MDCR AUC of 0.593 with 14-day lookback vs. AUC of 0.631 with all-time lookback) and 0.012 for renal impairment (in MDCR AUC of 0.675 with 30-day lookback vs. AUC of 0.687 with 365-day lookback ). For the acute outcomes, the max difference in AUC across lookbacks within a database was 0.015 (in MDCD AUC of 0.767 with 14-day lookback vs. AUC 0.782 with 365-day lookback) for stroke and < 0.03 for gastrointestinal bleeding (in CCAE AUC of 0.631 with 14-day lookback vs. AUC of 0.660 with 730-day lookback).

Conclusions: In general the choice of covariate lookback had only a small impact on discrimination and calibration, with a short lookback (< 180 days) occasionally decreasing discrimination. Based on the results, if training a logistic regression model for prediction then using covariates with a 365 day lookback appear to be a good tradeoff between performance and interpretation.

Citing Articles

Development and validation of a patient-level model to predict dementia across a network of observational databases.

John L, Fridgeirsson E, Kors J, Reps J, Williams R, Ryan P BMC Med. 2024; 22(1):308.

PMID: 39075527 PMC: 11288076. DOI: 10.1186/s12916-024-03530-9.


Machine Learning and Real-World Data to Predict Lung Cancer Risk in Routine Care.

Chandran U, Reps J, Yang R, Vachani A, Maldonado F, Kalsekar I Cancer Epidemiol Biomarkers Prev. 2022; 32(3):337-343.

PMID: 36576991 PMC: 9986687. DOI: 10.1158/1055-9965.EPI-22-0873.


OMOP CDM Can Facilitate Data-Driven Studies for Cancer Prediction: A Systematic Review.

Ahmadi N, Peng Y, Wolfien M, Zoch M, Sedlmayr M Int J Mol Sci. 2022; 23(19).

PMID: 36233137 PMC: 9569469. DOI: 10.3390/ijms231911834.

References
1.
Kim M, Chae K, Chung Y, Hwang H, Lee M, Kim H . The effect of the look-back period for estimating incidence using administrative data. BMC Health Serv Res. 2020; 20(1):166. PMC: 7057623. DOI: 10.1186/s12913-020-5016-y. View

2.
Moskovitch R, Shahar Y, Wang F, Hripcsak G . Temporal biomedical data analytics. J Biomed Inform. 2019; 90:103092. PMC: 9745669. DOI: 10.1016/j.jbi.2018.12.006. View

3.
Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P . Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007; 335(7611):136. PMC: 1925200. DOI: 10.1136/bmj.39261.471806.55. View

4.
Zhang J, Iwashyna T, Christakis N . The performance of different lookback periods and sources of information for Charlson comorbidity adjustment in Medicare claims. Med Care. 1999; 37(11):1128-39. DOI: 10.1097/00005650-199911000-00005. View

5.
Berg G, Gurley V . Development and validation of 15-month mortality prediction models: a retrospective observational comparison of machine-learning techniques in a national sample of Medicare recipients. BMJ Open. 2019; 9(7):e022935. PMC: 6661632. DOI: 10.1136/bmjopen-2018-022935. View